← Open Payments lookup

MICHAEL YEBOAH: Open Payments

NPI 1285253559 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,754 in 99 payments from 19 companies in 2025. Trend: 2023 $233 · 2024 $1,705 · 2025 $4,754

Food & beverage: $4,754
CompanyPaymentsAmount
Gilead Sciences, Inc.9$781
Amgen Inc.10$603
Lilly USA, LLC9$459
AstraZeneca Pharmaceuticals LP5$417
ABBVIE INC.24$385
Novo Nordisk Inc10$330
GlaxoSmithKline, LLC.7$324
Kowa Pharmaceuticals America, Inc.2$233
ViiV Healthcare Company2$226
Dexcom, Inc.6$212

Products named: REPATHA, Yeztugo, UBRELVY, Descovy, ZORYVE, NUCALA, APRETUDE, DUPIXENT.

Industry payments across CA — which companies pay providers there.